During the past decade, Tuscaloosa Research & Education Advancement Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tuscaloosa Research & Education Advancement Corporation" #1 collaborator was "Abbott" with 1 trials as a collaborator, "American Society of Health-System Pharmacists Research and Education Foundation" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator and "Ortho-McNeil Janssen Scientific Affairs, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Tuscaloosa Research & Education Advancement Corporation" are "PTSD" (2 trials), "Bipolar Depression" (1 trials), "Hypercholesterolemia" (1 trials), "Hyperlipidemia" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Tuscaloosa Research & Education Advancement Corporation" in a lesser frequency.

Most popular intervention types in "Tuscaloosa Research & Education Advancement Corporation" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Colestipol" (1 trials), "Divalproex" (1 trials), "Ezetimibe" (1 trials), "Niacin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tuscaloosa Research & Education Advancement Corporation" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tuscaloosa Research & Education Advancement Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tuscaloosa Research & Education Advancement Corporation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tuscaloosa Research & Education Advancement Corporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".